Nanosuspensions of Selexipag: Formulation, Characterization, and in vitro Evaluation
Selexipag is an orally selective long-acting prostacyclin receptor agonist, which indicated for the treatment of pulmonary arterial hypertension. It is practically insoluble in water ( class II, according to BCS). This work aims to prepare and optimized Selexipag nanosuspensions to achieve an enhanc...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
College of Pharmacy University of Baghdad,
2021-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|